WO2005058156A1 - A system and a method for analysing ecg curvature for long qt syndrome and drug influence - Google Patents

A system and a method for analysing ecg curvature for long qt syndrome and drug influence Download PDF

Info

Publication number
WO2005058156A1
WO2005058156A1 PCT/DK2004/000722 DK2004000722W WO2005058156A1 WO 2005058156 A1 WO2005058156 A1 WO 2005058156A1 DK 2004000722 W DK2004000722 W DK 2004000722W WO 2005058156 A1 WO2005058156 A1 WO 2005058156A1
Authority
WO
WIPO (PCT)
Prior art keywords
parameters
tstart
tend
tpeak
ecg
Prior art date
Application number
PCT/DK2004/000722
Other languages
French (fr)
Inventor
Thomas Bork Hardahl
Claus Graff
Mads Peter Andersen
Egon Toft
Johannes Jan Struijk
Jørgen Kim KANTERS
Original Assignee
Aalborg Universitet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aalborg Universitet filed Critical Aalborg Universitet
Priority to US10/596,617 priority Critical patent/US7991458B2/en
Priority to JP2006544212A priority patent/JP2007514488A/en
Priority to CA002550224A priority patent/CA2550224A1/en
Priority to EP04762941A priority patent/EP1696792A1/en
Publication of WO2005058156A1 publication Critical patent/WO2005058156A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods

Definitions

  • the present invention relates to a system for analysing drug influence on ECG curvature and Long QT Syndrome where at least one among a number of different parameters is isolated, which system has an input means connected to an ECG source, where the different parameters of a received ECG curvature are indicated and/or isolated and for indicating possible symptoms.
  • the present invention further relates to a method for analysing drug influence on ECG curvature, which curvature contains a number of parameters.
  • the heart generates an electrical signal which can be measured as an ECG, which can be recorded as an ECG diagram.
  • ECG-signal P,Q,R,S,T and U are due to depolarisation and repolarisation of the heart.
  • Ponset 2 marks the beginning of the P wave.
  • Qonset 4 marks the beginning of the Q wave.
  • Rpeak 6 marks the top of the R wave.
  • the Jpoint 8 marks the end of the S wave.
  • Tstart 10 marks the beginning of the T wave.
  • Tpeak marks 12 the top of the T wave.
  • Tend 14 marks the end of the T wave.
  • the QT interval starts at Qonset 4 and ends at Tend 14.
  • the QT curvature is the part of the ECG curvature between Qonset 4 and Tend 14.
  • US 5, 749,367 describes a heart monitoring apparatus and method wherein an electrocardiograph signal is obtained from a patient and processed to enhance the salient features and to suppress noise.
  • a plurality n of values representative of the features of the electrocardiograph signal are generated and used in a Kohonen neural network to gen- erate an n dimensional vector.
  • This vector is compared with a stored plurality m of n dimensional reference vectors defining an n dimensional Kohonen feature map to determine the proximity of the vector to the reference vectors. If it is determined by the Kohonen neural network that the vector is within or beyond a threshold range of the reference vectors, a signal is the output, which can be used to initiate an event such as the generation of an alarm or the storage of ECG data.
  • US 2002/143263 describes a system comprised of a medical device and a method for analyzing physiological and health data and representing the most significant parameters at different levels of detail, which are understandable to a lay person and a medi- cal professional.
  • Low, intermediate and high-resolution scales can exchange information between each other for improving the analyses; the scales can be defined according to the corresponding software and hardware resources.
  • a low-resolution Scale I represents a small number of primary elements such as the intervals between the heart beats, duration of electrocardiographic PQ, QRS, and QT-intervals, amplitudes of P-, Q-, R-, S-, and T-waves. This real-time analysis is implemented in a portable device that requires minimum computational resources.
  • the set of primary elements and their search criteria can be adjusted using intermediate or high-resolution levels.
  • serial changes in each of the said elements can be determined using a mathematical decomposition into series of basis functions and their coefficients.
  • This scale can be implemented using a specialized processor or a computer organizer.
  • high-resolution Scale III combined serial changes in all primary elements can be determined to provide complete information about the dynamics of the signal.
  • This scale can be implemented using a powerful processor, a network of computers or the Internet.
  • the system can be used for personal or group self- evaluation, emergency or routine ECG analysis or continuous event, stress-test or bedside monitoring.
  • the aim of the invention is to achieve a system and a method for diagnosing Long QT Syndrome in an objective, fast and effective way by indication of a number of symptoms derivable from an ECG curve.
  • a further aim of the invention is to achieve an effective test of drug influence on ECG curvature.
  • any symptom of Long QT Syndrome having an indication (influence) in the ECG curvature can be detected in an objective, automated and very fast way.
  • the system might be used under field conditions such as in ambulances or in other situations where a fast indication of heart diseases is needed in order to help the patient in a correct way as early as possible.
  • the analysis that takes place in an ambulance on its way to the hospital can by transmitting the results to the hospital allow the doctor at the hospital to give feedback to the personnel in the ambulance so that the correct treatment of the patient may start.
  • the hospital can prepare the correct activity for the incoming patient.
  • the system could be very important for
  • the system can analyse drug influence on a number of persons, where analyses are made before and repeated after drug influence, where selected parameters are compared and/or combined. It is, hereby, achieved that a drug might be tested for having influence on the ECG curvature of a number of persons. This can be very important for accentance of new drugs. This svstem and also described as a method is able to relatively short period, and where the decision if a new drug should be rejected because of having negative influence of the ECG, or the drug can be accepted. This decision can be taken relatively fast.
  • ECG curvature from a source, - indicating a number of different parameters contained in the received ECG curvature, - storing the parameters in storage means, selecting disease specific parameters in the storage means - selecting parameters from at least three groups, which groups comprise parameters of symmetry, flatness, duration and/or complexity - combining selected parameters in mathematical analysing means - representing the result of the mathematical analysis as a point in a coordinate system comprising at least one axis, - comparing the actual placement in the coordinate system with a number of reference parameters stored in a memory, - analysing the QT curvature of the ECG for indicating drug induced changes.
  • the analysing process can be repeated in the system for further selected parameters in order to achieve more reliable results.
  • the system or the method can be repeated several times with different combinations of parameters.
  • a deviation of parameters from the stored data indicating symptoms of Long QT Syndrome or drug influence may also be interpreted for further reference.
  • the system or method analyses the parameters chosen from at least three main groups, such as groups of parameters of symmetry, flatness, complexity and duration relating tn thfi actual ECG curvature. In this wav. it is achieved that the parameters are grouped cific number of possible parameters. Keeping the number of parameters relatively small, the analysis takes place in a faster way.
  • the group of symmetry might comprise at least the following parameters:
  • v[n] is the ECG signal.
  • Tpeakjend Tend — Tpeak and v[n] is the ECG signal.
  • v[n] is the ECG signal.
  • F4 Flatness parameter, F3 normalized by the size of the R wave, calculated by t thhee f foorrmmuullaa-: F3 FA - I v[Rpe ⁇ :] - v[Jpo int]
  • v[n] is the ECG signal.
  • Tstart-Tend-interval surrounding Tpeak calculated by the formula:
  • n Tstart A and v[n] is the ECG signal.
  • F8 Flatness parameter, F7 normalized by the size of the R wave, calculated by the formula: p% - E7 I v[Rpea&] - v[jpo int]
  • v[n] is the ECG signal.
  • v[n] is the ECG signal.
  • F9 Flatness parameter, F9, normalized by the size of the R wave, calculated by the formula: E9 10 : v[Rpe ⁇ Ar] - v[jpo int]
  • E9 10 v[Rpe ⁇ Ar] - v[jpo int]
  • E16 v[Tpeak], where v[n] is the ⁇ CG signal.
  • N max The Hill parameter, evaluated by least square fitting of the repolarisa- tion integral, RI(t), from the Jpoint to the following Ponset as described by Kanters et al., "T wave morphology analysis distinguishes between KvLQTl and HERG mutations in long QT syndrome", Heart Rhythm (2004) 3, 285-292:
  • QTc The Q-T interval normalized by the square root of the R-R interval according to Razett's formula: _ Tend - Qoi ⁇ set RR
  • the group of complexity might contain at least the following parameters:
  • C2 Number of phases between Tstart and Tend, where a phase is defined as a singly connected part of the wave that is entirely above or entirely below the iso-electric line; the minimum number is one.
  • the groups of parameters could contain further parameters, and the groups may contain a number of subgroups.
  • the parameters can be an elevation of the curve; they can be the morphology of the curve; or they could be time- deviations as an example of possible parameters.
  • a pre- cise analysis can take place because a specific combination of parameters can indicate
  • the system and/or method can analyse the QT curvature of the ECG for indicating
  • the Long QT syndrome can be indicated in an objective and effective manner which might occur in postsyncopal cardiac examination.
  • the method can differentiate between different genotypes of the Long QT Syndrome, which is important for the treatment. It can, hereby, be achieved that the correct medical treatments can be started.
  • the system and the method can be used for test of drug influence on ECG curvature.
  • the system can be trained, where the parameters' values are calculated for individual subjects, where an analysis of the parameters is performed such as a pattern classification method based on supervised learning, such as Discriminant Analysis, Nearest Neighbor Techniques, Multilayer Neural Networks, Decision Trees and Rule Based Methods or combinations of these.
  • supervised learning such as Discriminant Analysis, Nearest Neighbor Techniques, Multilayer Neural Networks, Decision Trees and Rule Based Methods or combinations of these.
  • the final classification function is at least based on data from at least one LQT or drug influenced group and Normal subjects stored as a training set with the consequences that the classification method is improved by adding new subjects to the training set, which new subject can be tailored to demographic or gender differences.
  • reference values based on the training set can be selected from the most critical group of persons with reference to the parameters that are going to be tested.
  • the mathematical analysis chooses the optimal (small) parameter set out of the complete set (large) from all categories, which values are stored as ref. values. It should be made clear that the final classification functions are based on data from at least one LQT or drug influenced group and Normal subjects (the training set) with the consequences that the dis-
  • This invention also comprises the use of a system for analysing ECG curvature for test of drugs, which system has input means connected to an ECG source, wherein at least one among a number of different parameters is isolated and stored in the system, where the different parameters of a received ECG curvature are indicated and/or isolated for indicating possible symptoms, where a number of selected parameters, are combined in at least a first mathematical analysis, where the result of the analysis is represented as a point in at least one coordinate system, comprising at least one axis, where the system compares the actual placement in the coordinate system with a number of reference parameters stored in the system, for indicating symptoms having influence on the ECG curvature, and analysing the QT curvature of the ECG for indicating drug induced changes to the ECG curvature, where the parameters of the ECG curvature are calculated before and after a drug test for a number of subjects, where the difference for selected parameters between before and after testing is calculated for each subject, where a mathematical analysis of selected parameters for a number of subjects gives statistical significance for
  • the Long QT Syndrome is a genetic disorder characterized by abnormal cardiac repolarisation resulting in prolonged QT duration, syncopal episodes and increased risk of than 90% of all LQTS patients.
  • the QT interval duration is the only ECG-based quantifier of LQTS used in clinical practice today. However duration is only a gross estimate of repolarisation and does not allow perfect discrimination between KvLQTl, HERG and normal subjects. Studies have shown that T-wave morphology parameters are useful discriminators in LQTS, but no single parameter has proven to be sufficient.
  • Stepwise discriminant analysis was performed to obtain two discriminant functions based on the five strongest discriminatory parameters.
  • the resulting discriminant functions include 2 duration-, 2 symmetry- and 1 flatness parameter.
  • the two functions classify all subjects correctly (p> 0.0001, p ⁇ 0.005).
  • Further discriminant analysis with a reduced number of parameter categories implied that superior classification is obtained when using all three parameter categories presented.
  • a combination of parameters from the three categories symmetry, flatness and duration of repolarisation was sufficient to correctly classify ECG recordings from the KvLQTl, HERG and normal subjects in this study. This multivariate approach may prove to be a powerful clinical tool.
  • LQTS Long QT Syndrome
  • the duration of the QT interval is only a gross estimate of repolarisation since T-wave morphology is also important when characterizing the QT interval. This is evidenced by the fact that approximately 10% of all mutation carriers have a normal Bazett corrected QTc ( ⁇ 440ms) and 40% of KvLQTl and HERG carriers show QTc values between 410-470 ms that overlap with non-carriers. Conversely only 2% of all carriers present with a normal ST-T pattern and a normal QT interval. Morphological aberrations thus carry major implications for the identification of ab- normal repolarisation and have been included as diagnostic criteria equivalent to that of a positive family history for LQTS.
  • Cardiologists already include a qualitative assessment of T-wave morphology from the ECG in order to obtain information that augments the clinically established QT interval measurement and facilitates discrimination between LQTS genotypes.
  • qualitative description of repolarisation morphology may be biased due to intra- and interpersonal variability thus indicating the need for a standardized quantitative measure of this parameter.
  • Data acquisition was carried out with the subjects resting in supine position.
  • the equipment used for data acquisition was a portable digital ECG recording system, "Cardio Perfect Resting ECG system” manufactured by Cardiocontrol. Recording was divided into three sessions. Data was collected from 8 leads (I-III, N2-N6) with a sampling rate of 1200Hz. Signal recording length was 75 s. in the first session and 150 s. in the last two sessions.
  • the method is based on prior work published by Website et al. and uses adaptive thresholdin ⁇ techni ⁇ ues aonlied to a dieitallv filtered and differentiated sienal. A mi- nor extension to the algorithm was incorporated to enable the detection of Tstart. Tstart was detected with a technique equivalent to the technique for detecting Tend.
  • Figure 2 shows an example of the result of the event detection algorithm.
  • the QT interval and the repolarisation process was done on the basis of an ECG signal with stabilized baseline. This was achieved through preliminary signal processing.
  • the "raw" ECG was filtered by a Kaiser window high pass filter with a cut-off frequency of 0,5 Hz, 40 dB damping in 0,25 Hz and 0,1 dB ripple in the pass- band.
  • Other filters are subsequently used: a lowpassfilter for noise reduction and a notch filter for reduction of 50 Hz or 60 Hz interference.
  • the isoelectric line is defined as the straight line that connects the PQ interval before the QT interval at hand and the PQ interval after the QT interval at hand. The iso-electric line relative to zero is subtracted from the QT interval analysed.
  • T-wave morphology In order to characterize the T-wave morphology, a number of parameters were selected. The parameters were chosen to cover each of the three categories: Twave symmetry, T-wave flatness and duration. The parameters are listed and described in table 1.
  • Parameters S1-S4 and F1-F8 is based on the calculation of modified skewness and kurtosis measures defined as symmetry and flatness in the following.
  • the T- waves were modelled as probability mass distributions (figure 3) and assigned a centre
  • m2 is the standard deviation of the signal:
  • FIG. 2 Isoelectric lines (dashed lines) in the signal are calculated from one P-Q interval to the following P-Q interval (Qstart - 20 ms). The line values are subtracted from the corresponding ECG signal values giving the distances v(n). The result of this procedure is shown as an area plot with basis on the zero-line.
  • Figure 3 a) Example probability mass distribution used when calculating standard skewness and kurtosis measures, b) Modified frequency distribution used in this study for calculating the modified skewness and kurtosis measures. Signal values v(n) are shown in figure 2. PARAMETER DESCRIPTION
  • F5 Kurtosis evaluated in a symmetric interval 10 % of the Tstart-Tend interval surrounding Ttop with Ttop as mean.
  • F6 F5 normalized by absolute Rtop-Qnadir value.
  • F 10 F9 normalized by absolute Rtop-Qnadir value.
  • QTc The Q-T interval normalized by the square root of the R-R interval according to Bazett's formula.
  • D2 Time interval from Tstart to Tend D3 Time interval from Tstart to Ttop. D4 Time interval from Ttop to Tend.
  • the table above shows a Complete list of the parameters used to characterize T-wave morphology. Parameters belong to one of three categories: symmetry, flatness and duration.
  • m3 is the modified skewness of the signal:
  • m4 is the modified kurtosis of the signal:
  • T-wave morphology parameters for the acquired, pre-processed ECG recordings were evaluated using Matlab 6.0. Only valid data were analyzed - i.e. data from leads where the signal was not corrupted by high frequency noise and where the event detection algorithm was successful in detecting the relevant events with satisfactory precision. Parameter means and standard deviations were calculated for every T-wave in the signal on all leads. A great interlead variation in T-wave morphology may be an indicator of LQTS. Interlead variance was therefore examined by calculating the standard deviation of the lead means for each parameter.
  • Figure 4 Scatterplot showing classification of individuals by genotype. Separation of groups was carried out by 2 discriminant functions with 5 variables that characterize repolarisation by computation of symmetry, flatness and duration. 3. Results
  • the discriminant functions were based on data from all KvLQTl, HERG and normal subjects.
  • the 5 parameters included in both discriminant functions are listed in table 2.
  • the discriminative efficiency of both generated functions was statistically significant after inclusion of all 5 parameters (function 1: pO.OOOl, function 2: p ⁇ 0.005).
  • a scatterplot was generated from the discrimination functions and groupings of indi- vidual genotypes can be seen in figure 4.
  • the dotted lines were read from the SPSS generated territorial map and manually added. The lines reflect borderlines where the differences between each pair of discrimination functions are zero. All 16 processed ECG's were correctly classified and showed at least one discriminatory characteristic as defined by the 5 parameters included in the discrimination functions. Cross valida- tion of both discriminant functions was done with the leave-one-out method and all 16 subjects were again correctly grouped. Reducing the number of variables resulted in misclassified cases due to lack of one or more discriminatory characteristics.
  • HERG and KvLQTl was higher than that of normal individuals (figure 5e). However overlap existed between all three groups preventing separation of the groups by QTc. Since no single parameter included in the discrimination functions was able to separate KvLQTl, HERG and normal, we proceeded to investigate the classification effi- ciency provided by the three primary categories represented by the parameters in the functions. This was carried out by generating new discrimination functions using parameters from one category only while excluding the other two. Then, from the new discrimination functions three additional functions were generated, this time allowing the inclusion of parameters from combinations of two categories. Scatterplots illustrat- ing the results of this analysis are shown in figures 6a-f.
  • the first two functions included parameters that characterize the symmetrical properties of the Twave. 83.1% of the 16 subjects were correctly classified. Arrows in figure 6a indicate the 3 misclassified subjects. A second discriminant analysis was performed using flatness parameters. This resulted in 93.8% correctly classified subjects. Only one subject was not correctly classified as indicated by the arrow on figure 6b. The misclassified case was the same HERG subject incorrectly classified using symmetry parameters. The discriminatory efficiency of duration parameters was also evaluated. Discrimination nna1v ⁇ ji ⁇ 3 p. ⁇ nltp.d in 93.8% correctlv classified sub ects. One HERG subject was mis- waves similar to those found in KvLQTl. However the duration parameters failed to identify this morphological feature, thus reducing classification performance.
  • S4meanN5 - Lead N5 mean modified skewness evaluated in a symmetrical interval surrounding Ttop and corresponding to 20% of the interval between Tstart-Tend. c) D4std - Interlead standard deviation of the time interval from Ttop to Tend, d) S5meanN5 - Lead N5 mean of the ratio between the time interval from Tstart to Ttop and the corresponding time interval from Ttop to Tend, e) Lead N5 mean QTc.
  • Figures 6d-f show the results of three separate discriminant analysis using combinations of parameters from two categories. It can be noted that classification of subjects was perfect in all cases, even when repolarisation duration was not considered (figure 6d).
  • Figure 6. a) The result of discriminant analysis using symmetry parameters resulted in three misclassified cases (arrows). Visual inspection of the ECG's revealed no apparent abnormalities to indicate the reason for incorrect misclassification. b) The result of discriminant analysis using flatness parameters. One incorrectly classified HERG subject was identified (arrow) even though no obvious visual abnormality indicated a different genotype, c) Result of discriminant analysis using duration parameters.
  • QTc parameter alone emphasizes the hypothesis that additional parameters are needed to classify LQTS individuals. By combining parameters from two categories it was found that the discriminatory strength was increased.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a system or a method for analysing drug influence on ECG curvature and Long QT Syndrome where at least one among a number of different parameters is isolated, which system has a input means connected to an ECG source, where the different parameters of a received ECG curvature and indicated and/or isolated and for indicating possible symptoms which relates to or are indications of certain diseases, where said diseases are known to influence the ECG curvature. The aim of the invention is to achieve a system and a method for diagnosing Long QT Syndrome in an objective, fast and effective way by indication of a number of symptoms derivable from an ECG curve. Further aim of the invention is to achieve an effective test of drug influence on ECG curvature. This can be achieved with the system previously described if a first number of selected parameters is combined in at least a first mathematical analysis, where the result of the analysis can be represented as a point in a coordinate system comprising at least one axis where the system can compare the actual placement in the coordinate system with a number of reference parameters stored in the system for indicating symptoms or diseases having influence on the ECG curvature, where the system analyses the QT curvature of the ECG curvature for indicating Long QT syndrome. Hereby, it is achieved that any symptom of hereditary or acquired Long QT Syndrome having an indication (influence) in the ECG curvature can be detected in an objective, automated and very fast way.

Description

A system and a method for analysing ECG curvature for Long QT Syndrome and drug influence.
The present invention relates to a system for analysing drug influence on ECG curvature and Long QT Syndrome where at least one among a number of different parameters is isolated, which system has an input means connected to an ECG source, where the different parameters of a received ECG curvature are indicated and/or isolated and for indicating possible symptoms.
The present invention further relates to a method for analysing drug influence on ECG curvature, which curvature contains a number of parameters.
The heart generates an electrical signal which can be measured as an ECG, which can be recorded as an ECG diagram. The waves in the ECG-signal P,Q,R,S,T and U are due to depolarisation and repolarisation of the heart.
Intervals and complexes are illustrated on a typical ECG curvature, see fig. 1 in order to illustrate the different curve sections isolated by the analysis and referred to by parameters, intervals and complexes comprising the following annotations, where
Ponset 2 marks the beginning of the P wave. Qonset 4 marks the beginning of the Q wave. Rpeak 6 marks the top of the R wave. The Jpoint 8 marks the end of the S wave.
Tstart 10 marks the beginning of the T wave. Tpeak marks 12 the top of the T wave. Tend 14 marks the end of the T wave.
The QT interval starts at Qonset 4 and ends at Tend 14.
The QT curvature is the part of the ECG curvature between Qonset 4 and Tend 14.
The RR interval goes from one R-peak 6 to the following R-peak 7. US 5, 749,367 describes a heart monitoring apparatus and method wherein an electrocardiograph signal is obtained from a patient and processed to enhance the salient features and to suppress noise. A plurality n of values representative of the features of the electrocardiograph signal are generated and used in a Kohonen neural network to gen- erate an n dimensional vector. This vector is compared with a stored plurality m of n dimensional reference vectors defining an n dimensional Kohonen feature map to determine the proximity of the vector to the reference vectors. If it is determined by the Kohonen neural network that the vector is within or beyond a threshold range of the reference vectors, a signal is the output, which can be used to initiate an event such as the generation of an alarm or the storage of ECG data.
US 2002/143263 describes a system comprised of a medical device and a method for analyzing physiological and health data and representing the most significant parameters at different levels of detail, which are understandable to a lay person and a medi- cal professional. Low, intermediate and high-resolution scales can exchange information between each other for improving the analyses; the scales can be defined according to the corresponding software and hardware resources. A low-resolution Scale I represents a small number of primary elements such as the intervals between the heart beats, duration of electrocardiographic PQ, QRS, and QT-intervals, amplitudes of P-, Q-, R-, S-, and T-waves. This real-time analysis is implemented in a portable device that requires minimum computational resources. The set of primary elements and their search criteria can be adjusted using intermediate or high-resolution levels. At the intermediate-resolution Scale II, serial changes in each of the said elements can be determined using a mathematical decomposition into series of basis functions and their coefficients. This scale can be implemented using a specialized processor or a computer organizer. At the high-resolution Scale III, combined serial changes in all primary elements can be determined to provide complete information about the dynamics of the signal. This scale can be implemented using a powerful processor, a network of computers or the Internet. The system can be used for personal or group self- evaluation, emergency or routine ECG analysis or continuous event, stress-test or bedside monitoring. The aim of the invention is to achieve a system and a method for diagnosing Long QT Syndrome in an objective, fast and effective way by indication of a number of symptoms derivable from an ECG curve. A further aim of the invention is to achieve an effective test of drug influence on ECG curvature.
This can be achieved with the system previously described if a first number of selected parameters from at least three main groups, which groups comprise parameters of symmetry, flatness, duration and/or complexity, which parameters are combined in at least a first mathematical analysis, which relate to or are indications of certain dis- eases, where said diseases are known to influence the ECG curvature, where the result of the analysis can be represented as a point in a coordinate system comprising at least one axis where the system can compare the actual placement in the coordinate system with a number of reference parameters stored in the system for indicating symptoms or diseases having influence on the ECG curvature, where the system analyses the QT curvature of the ECG curvature for indicating Long QT syndrome.
Hereby, it is achieved that any symptom of Long QT Syndrome having an indication (influence) in the ECG curvature can be detected in an objective, automated and very fast way. The system might be used under field conditions such as in ambulances or in other situations where a fast indication of heart diseases is needed in order to help the patient in a correct way as early as possible. The analysis that takes place in an ambulance on its way to the hospital can by transmitting the results to the hospital allow the doctor at the hospital to give feedback to the personnel in the ambulance so that the correct treatment of the patient may start. At the same time, the hospital can prepare the correct activity for the incoming patient. The system could be very important for
ECG analyses for all non-specialists in the field if they have to analyse an ECG curvature.
The system can analyse drug influence on a number of persons, where analyses are made before and repeated after drug influence, where selected parameters are compared and/or combined. It is, hereby, achieved that a drug might be tested for having influence on the ECG curvature of a number of persons. This can be very important for accentance of new drugs. This svstem and also described as a method is able to relatively short period, and where the decision if a new drug should be rejected because of having negative influence of the ECG, or the drug can be accepted. This decision can be taken relatively fast.
The scope of the invention can also be fulfilled with a method for analysing the drug influence on the ECG curvature if the method incorporates the steps of:
- receiving ECG curvature from a source, - indicating a number of different parameters contained in the received ECG curvature, - storing the parameters in storage means, selecting disease specific parameters in the storage means - selecting parameters from at least three groups, which groups comprise parameters of symmetry, flatness, duration and/or complexity - combining selected parameters in mathematical analysing means - representing the result of the mathematical analysis as a point in a coordinate system comprising at least one axis, - comparing the actual placement in the coordinate system with a number of reference parameters stored in a memory, - analysing the QT curvature of the ECG for indicating drug induced changes.
In this way as already described, a very effective analysis of the ECG curvature is achieved.
The analysing process can be repeated in the system for further selected parameters in order to achieve more reliable results. Hereby, it is achieved that the system or the method can be repeated several times with different combinations of parameters. With the system, a deviation of parameters from the stored data indicating symptoms of Long QT Syndrome or drug influence may also be interpreted for further reference.
The system or method analyses the parameters chosen from at least three main groups, such as groups of parameters of symmetry, flatness, complexity and duration relating tn thfi actual ECG curvature. In this wav. it is achieved that the parameters are grouped cific number of possible parameters. Keeping the number of parameters relatively small, the analysis takes place in a faster way.
The group of symmetry might comprise at least the following parameters:
SI Symmetry evaluated from Tstart to Tend, calculated by the formula:
Figure imgf000007_0001
where w tt\ = v\n l m0 , Tend mj = ∑ra - w[n], n=Tstart
Figure imgf000007_0002
and v[n] is the ECG signal.
S2 Symmetry with Tpeak as mean evaluated from Tstart to Tend, calculated by the formula:
S2 =
Figure imgf000007_0003
where w[n] =
Figure imgf000007_0004
Tend
and v[n] is the ECG signal.
S3 Symmetry with Tpeak as mean evaluated in a symmetric interval of 10% of the Tstart-Tend-interval surrounding Tpeak, calculated by the formula:
S3 =
Figure imgf000007_0005
where w[n] =
Figure imgf000007_0006
Figure imgf000007_0007
and v[n] is the ECG signal.
S4 Syimnetry with Tpeak as mean evaluated in a symmetric interval of 20% of the Tstart-Tend-interval surrounding Tpeak, calculated by the formula: S4 =
where
Figure imgf000008_0001
Tend mO = ∑v[n] n=Tstart and v[n] is the ECG signal.
S5 Ratio of the time interval "Tstart to Tpeak" and the time interval "Tpeak to
Tend", calculated by the formula: Tpeak - Tstart
S5 = - Tend — Tpeak
S6 Ratio of the average slope from Tstart to Tpeak and from Tpeak to Tend Slope
S6 = T. startjpeak Sl°PeTpeak,Tend where v[Tpeak] -v[Tstart] SlopeTstarK Tpeak Tpeak -Tstart v[Tend] - v[Tpeak]
Slope. Tpeakjend Tend — Tpeak and v[n] is the ECG signal.
S7 Nariation evaluated from Tstart to Tend, calculated by the formula:
Figure imgf000008_0002
where w[n] = v[n]/ m0 , Tend n=Tstart T leennda = ∑v[»] n=Tstart and v[n] is the ECG signal.
S8 Nariation with Tpeak as mean evaluated from Tstart to Tend, calculated by the formula:
Figure imgf000008_0003
where w n | = v|n |/7??n ,
Figure imgf000009_0001
and v[n] is the ECG signal.
S9 Nariation with Tpeak as mean evaluated in a symmetric interval of 10% of the Tstart-Tend-interval surrounding Tpeak, calculated by the formula:
Figure imgf000009_0002
where w[n] = v[«]/m0 , Tend
0 = ∑v[«] n=Tstart and v[n] is the ECG signal
S10 Nariation with Tpeak as mean evaluated in a symmetric interval of 20% of the Tstart-Tend-interval surrounding Tpeak, calculated by the formula:
510 = • w[n]
Figure imgf000009_0003
where w[n] = v[n]/ 0 ,
Figure imgf000009_0004
and v[n] is the ECG signal.
SI 1 The Hill parameter, K„„ evaluated by least square fitting of the repolarisation integral, RI(t), from the Jpoint to the following Ponset as described by Kanters et al., "T wave morphology analysis distinguishes between KvLQTl and HERG mutations in long QT syndrome", Heart Rhythm (2004) 3, 285-292:
Figure imgf000009_0005
S12 The Hill parameter, K^, evaluated by least square fitting of the repolarisation integral, RI(t), from Tstart to Tend analogous to the method described by Kanters et al., "T wave morphology analysis distinguishes between KvLQTl and HERG mutations in long QT syndrome", Heart Rhythm (2004) 3, 285-292:
Figure imgf000009_0006
Fl Flatness evaluated from Tstart to Tend, calculated by the formula:
Figure imgf000009_0007
where w[n]= v[n]/m0 , Tend mι = - wW = nn=^TTssttaarrtt
Figure imgf000010_0001
and v[n] is the ECG signal.
F2 Flatness parameter, Fl, normalized by the size of the R wave, calculated by the formula:
F2= I v[Rpeαfcj n- v[J7oint] | ,
where v[n] is the ECG signal.
F3 Flatness with Tpeak as mean evaluated from Tstart to Tend, calculated by the formula: 3 =
Figure imgf000010_0002
where w[n] = v[n]/m0 , Tend m0 = ∑v[n] n=Tsl rt and v[n] is the ECG signal.
F4 Flatness parameter, F3, normalized by the size of the R wave, calculated by t thhee f foorrmmuullaa-: F3 FA - I v[RpeαΛ:] - v[Jpo int] | '
where v[n] is the ECG signal.
F5 Flatness with Tpeak as mean evaluated in a symmetric interval of 10% of the Tstart-Tend-interval surrounding Tpeak, calculated by the formula:
F5 =
where
Figure imgf000010_0003
Tend m» = n= ΣTstartVW and v[n] is the ECG signal. F6 Flatness parameter, F5, normalized by the size of the R wave, calculated by t thripe; f fπorrmtrmullaa-:
Figure imgf000011_0001
where v[n] is the ECG signal.
F7 Flatness with Tpeak as mean evaluated in a symmetric interval of 20% of the
Tstart-Tend-interval surrounding Tpeak, calculated by the formula:
Fl =
where
Figure imgf000011_0002
n Tstart A and v[n] is the ECG signal.
F8 Flatness parameter, F7, normalized by the size of the R wave, calculated by the formula: p% - E7 I v[Rpea&] - v[jpo int] | '
where v[n] is the ECG signal.
F9 Ratio of the total area under the T-wave from Tstart to Tpeak and the corresponding time interval, calculated by the formula:
Figure imgf000011_0003
where v[n] is the ECG signal.
F10 Flatness parameter, F9, normalized by the size of the R wave, calculated by the formula: E9 10 : v[RpeαAr] - v[jpo int] |
where v[n] is the ΕCG signal.
Fl 1 Ratio of the total area under the T-wave from Tpeak to Tend and the corresponding time interval, calculated by the formula:
Figure imgf000012_0001
where v[n] is the ECG signal.
F12 Flatness parameter, Fll, normalized by the size of the R wave, calculated by the formula: Ell E12 = v[Rpea£] - v[Jpo int] |
where v[n] is the ΕCG signal.
F13 Ratio of the total area under the T-wave from Tstart to Tend and the corresponding time interval, calculated by the formula:
Figure imgf000012_0002
Tf-i o n=Tstart Tend — Tstart where v[n] is the ΕCG signal.
F14 Flatness parameter, F13, normalized by the size of the R wave, calculated by t thhee f foorrmmuullaa: El 3 E14 = v[Rj9eαλ:]-v[Jpøint] | '
where v[n] is the ΕCG signal.
F 15 Ratio of the T wave height and the T wave width, calculated by the formula:
Tend - Tstart where v[n] is the ΕCG signal.
F 16 The T wave height, calculated by the formula:
E16 = v[Tpeak], where v[n] is the ΕCG signal.
F17 Average slope from Tstart to Tpeak, calculated by the formula: v[Tpeak] - vjTstart] F 18 Average slope from Tpeak to Tend, calculated by the formula:
Fl z _ v[Tend]-v[Tpeak] ^ Tend — Tpeak where v[n] is the ECG signal.
F19 The Hill parameter, n, evaluated by least square fitting of the repolarisation integral, RI(t), from the Jpoint to the following Ponset as described by Kanters et al.,
"T wave morphology analysis distinguishes between KvLQTl and HERG mutations in long QT syndrome", Heart Rhythm (2004) 3, 285-292:
Figure imgf000013_0001
F20 The Hill parameter, n, evaluated by least square fitting of the repolarisation integral, RI(t), from Tstart to Tend analogous to the method described by Kanters et al., "T wave morphology analysis distinguishes between KvLQTl and HERG mutations in long QT syndrome", Heart Rhythm (2004) 3, 285-292:
Figure imgf000013_0002
F21 The Hill parameter, Nmax, evaluated by least square fitting of the repolarisa- tion integral, RI(t), from the Jpoint to the following Ponset as described by Kanters et al., "T wave morphology analysis distinguishes between KvLQTl and HERG mutations in long QT syndrome", Heart Rhythm (2004) 3, 285-292:
Figure imgf000013_0003
F22 The Hill parameter, Nmax, evaluated by least square fitting of the repolarisation integral, RI(t), from Tstart to Tend analogous to the method described by Kanters et al., "T wave morphology analysis distinguishes between KvLQTl and HERG mutations in long QT syndrome", Heart Rhythm (2004) 3, 285-292:
Figure imgf000013_0004
QTc The Q-T interval normalized by the square root of the R-R interval according to Razett's formula: _ Tend - Qoiτset RR
D2 The time interval from Tstart to Tend, calculated by the formula: D2 = Tend - Tstart
D3 The time interval from Tstart to Tpeak, calculated by the formula: D3 - Tpeak - Tstart
D4 The time interval from Tpeak to Tend, calculated by the formula: DA = Tend - Tpeak
The group of complexity might contain at least the following parameters:
Cl : Number of local maxima between Tstart and Tend; the minimum number is one.
C2: Number of phases between Tstart and Tend, where a phase is defined as a singly connected part of the wave that is entirely above or entirely below the iso-electric line; the minimum number is one.
The parameters previously described can also be calculated and stored as intra- and inter-lead means and standard deviations.
The groups of parameters could contain further parameters, and the groups may contain a number of subgroups.
When combining parameters from different groups, a much better result is achieved than when only using parameters from the same group. The parameters can be an elevation of the curve; they can be the morphology of the curve; or they could be time- deviations as an example of possible parameters. When combining parameters, a pre- cise analysis can take place because a specific combination of parameters can indicate
Long QT Syndrome or drug influence on ECG curvature and it is possible to effectively select between ECG-signals that look very much alike, but which indicate dif- A selection of these parameters is possible so that special genetic combinations are known with reference to the different stored parameters. The system can be updated by new data selected from different sources.
The system and/or method can analyse the QT curvature of the ECG for indicating
Long QT syndrome. This way, the Long QT syndrome can be indicated in an objective and effective manner which might occur in postsyncopal cardiac examination.
The method can differentiate between different genotypes of the Long QT Syndrome, which is important for the treatment. It can, hereby, be achieved that the correct medical treatments can be started. The system and the method can be used for test of drug influence on ECG curvature.
The system can be trained, where the parameters' values are calculated for individual subjects, where an analysis of the parameters is performed such as a pattern classification method based on supervised learning, such as Discriminant Analysis, Nearest Neighbor Techniques, Multilayer Neural Networks, Decision Trees and Rule Based Methods or combinations of these.
The final classification function is at least based on data from at least one LQT or drug influenced group and Normal subjects stored as a training set with the consequences that the classification method is improved by adding new subjects to the training set, which new subject can be tailored to demographic or gender differences. In addition it is achieved that reference values based on the training set can be selected from the most critical group of persons with reference to the parameters that are going to be tested.
Once the parameters' values are calculated for individual subjects the mathematical analysis chooses the optimal (small) parameter set out of the complete set (large) from all categories, which values are stored as ref. values. It should be made clear that the final classification functions are based on data from at least one LQT or drug influenced group and Normal subjects (the training set) with the consequences that the dis-
Im,'„nt;nn mc n ΛQΠ
Figure imgf000015_0001
Ϊm«mmu1 in Iv αrlrlino- npw emhipr.t<3 tn trip; train- ing set, but also that the method can be tailored to demographic differences (for example in California LQT2 patients might be somewhat different than in Denmark: the method can cope with this simply by training the system with people from California for use in California and with people from Denmark for use in Denmark) or to other differences (for example gender differences). Other examples could be age differences, difference between infants and adults.
This invention also comprises the use of a system for analysing ECG curvature for test of drugs, which system has input means connected to an ECG source, wherein at least one among a number of different parameters is isolated and stored in the system, where the different parameters of a received ECG curvature are indicated and/or isolated for indicating possible symptoms, where a number of selected parameters, are combined in at least a first mathematical analysis, where the result of the analysis is represented as a point in at least one coordinate system, comprising at least one axis, where the system compares the actual placement in the coordinate system with a number of reference parameters stored in the system, for indicating symptoms having influence on the ECG curvature, and analysing the QT curvature of the ECG for indicating drug induced changes to the ECG curvature, where the parameters of the ECG curvature are calculated before and after a drug test for a number of subjects, where the difference for selected parameters between before and after testing is calculated for each subject, where a mathematical analysis of selected parameters for a number of subjects gives statistical significance for at least one of the following decisions: "accept of the drug", "rejection of the drug". "further testing of the drug".
A very effective way of accepting or rejecting a drug is achieved.
Below are described one possible method and a system to illustrate the invention.
Abstract
The Long QT Syndrome is a genetic disorder characterized by abnormal cardiac repolarisation resulting in prolonged QT duration, syncopal episodes and increased risk of than 90% of all LQTS patients. The QT interval duration is the only ECG-based quantifier of LQTS used in clinical practice today. However duration is only a gross estimate of repolarisation and does not allow perfect discrimination between KvLQTl, HERG and normal subjects. Studies have shown that T-wave morphology parameters are useful discriminators in LQTS, but no single parameter has proven to be sufficient.
In this study we present a novel multivariate discrimination method based on a combination of T-wave symmetry-, flatness- and duration parameters. 16 subjects were included in the study - 8 normal, 5 HERG and 3 KvLQTl patients. Genotypes were known for all LQTS patients, but one. Standard 12 - lead ECG's were recorded on each subject. An automatic ECG event detection algorithm was implemented. The signal was highpass filtered and normalized with respect to the isoelectric level to ensure a stable baseline. 4 parameters describing the duration of repolarisation, 6 symmetry- and 15 flatness parameters were calculated to characterize each of the T- waves. The mean values of lead N5 and the interlead standard deviations were used as pa- rameter values. Stepwise discriminant analysis was performed to obtain two discriminant functions based on the five strongest discriminatory parameters. The resulting discriminant functions include 2 duration-, 2 symmetry- and 1 flatness parameter. The two functions classify all subjects correctly (p> 0.0001, p<0.005). Further discriminant analysis with a reduced number of parameter categories implied that superior classification is obtained when using all three parameter categories presented. A combination of parameters from the three categories symmetry, flatness and duration of repolarisation was sufficient to correctly classify ECG recordings from the KvLQTl, HERG and normal subjects in this study. This multivariate approach may prove to be a powerful clinical tool.
1. Introduction
The Long QT Syndrome (LQTS) represents a hereditary genetic disorder characterized by the presence of prolonged QT duration on the ECG, syncopal episodes due to polymorphic ventricular tachycardia (torsade de pointes), and arrythinogenic sudden cardiac death.
Mutations involving 6 different genes have been identified in LQTS subjects. These mutations result in structural and functional changes in ion-channel proteins and cur- repolarisation patterns. The most prevalent genes affected in LQTS patients are KvLQTl and HERG which account for more than 90% of LQTS genotype patients. The current study focuses on carriers of these two genes. Although some attempts have been made to develop quantitative measures that link different repolarisation abnormalities to specific LQTS related channel-opathities these methods have so far failed to provide a solid diagnostic yield. In current practice the duration of the QT interval is the only widely accepted quantifier of ventricular repolarisation. Yet, it has been recognized that the duration of the QT interval is only a gross estimate of repolarisation since T-wave morphology is also important when characterizing the QT interval. This is evidenced by the fact that approximately 10% of all mutation carriers have a normal Bazett corrected QTc (<440ms) and 40% of KvLQTl and HERG carriers show QTc values between 410-470 ms that overlap with non-carriers. Conversely only 2% of all carriers present with a normal ST-T pattern and a normal QT interval. Morphological aberrations thus carry major implications for the identification of ab- normal repolarisation and have been included as diagnostic criteria equivalent to that of a positive family history for LQTS.
Studies have shown that affected KvLQTl patients generally show broad based T- waves with a normal to relatively high amplitude and often without a distinct T - wave onset. For individuals with mutations involving the HERG gene the aforementioned studies have generally found low amplitude T-waves with bifid T-waves in 60% or more of the carriers.
Cardiologists already include a qualitative assessment of T-wave morphology from the ECG in order to obtain information that augments the clinically established QT interval measurement and facilitates discrimination between LQTS genotypes. However qualitative description of repolarisation morphology may be biased due to intra- and interpersonal variability thus indicating the need for a standardized quantitative measure of this parameter.
In the following is presented a novel multivariate categorization method that allows discrimination between KvLQTl, HERG and normal individuals based on Twave mnrnbnloøv recorded from 12-lead ECG's. Hallmark morphological features of T- ing three primary T-wave characteristics to be assessed. These characteristics are symmetry, flatness and duration.
2. Methods
2.1 Subjects The study included ECG recordings from 8 female and 8 male subjects. The subjects were divided into four groups; 3 KvLQTl (aged 20-48, 2 females), 5 HERG (aged 13- 76, 2 females), 8 normal (aged 23-31, 4 females). Genotypes were known for all KvLQTl and HERG subjects with a single exception: 1 patient was categorized as a KvLQTl subject by anamnesis and ECG-analysis. In the normal group there were no reports of prior cardiac diseases or LQTS family precedent.
2.2 Data collection
Data acquisition was carried out with the subjects resting in supine position. The equipment used for data acquisition was a portable digital ECG recording system, "Cardio Perfect Resting ECG system" manufactured by Cardiocontrol. Recording was divided into three sessions. Data was collected from 8 leads (I-III, N2-N6) with a sampling rate of 1200Hz. Signal recording length was 75 s. in the first session and 150 s. in the last two sessions.
Following data acquisition, SCP files generated by the Cardio perfect software were exported from a MSDE/SQL7 server and subsequently converted to .MAT files using
SCP-Batch Converter.
2.3 Algorithm for detection of events in the ECG
To facilitate evaluation of the repolarisation process and the QT interval, several events in the ECG were detected (Qstart, Rtop, Tstart, Ttop and Tend). An algorithm for detecting these events was implemented in Matlab 6.0.
The method is based on prior work published by Laguna et al. and uses adaptive thresholdinε techniαues aonlied to a dieitallv filtered and differentiated sienal. A mi- nor extension to the algorithm was incorporated to enable the detection of Tstart. Tstart was detected with a technique equivalent to the technique for detecting Tend. Figure 2 shows an example of the result of the event detection algorithm.
Figure 2. Important events that are used to describe repolarisation are marked by dots by the event detection algorithm. The algorithm is able to detect the events on all 8 recorded leads.
2. 4 Preliminary signal processing
Evaluation of the QT interval and the repolarisation process was done on the basis of an ECG signal with stabilized baseline. This was achieved through preliminary signal processing. The "raw" ECG was filtered by a Kaiser window high pass filter with a cut-off frequency of 0,5 Hz, 40 dB damping in 0,25 Hz and 0,1 dB ripple in the pass- band. Other filters are subsequently used: a lowpassfilter for noise reduction and a notch filter for reduction of 50 Hz or 60 Hz interference. The isoelectric line is defined as the straight line that connects the PQ interval before the QT interval at hand and the PQ interval after the QT interval at hand. The iso-electric line relative to zero is subtracted from the QT interval analysed. After filtering, the signal had an almost stable baseline. In order to improve stability, isoelectric lines in the signal were estimated from one P-Q interval (Qstart minus 20 ms) to the following P-Q interval (Qstart minus 20 ms). The signal was then normalized by subtracting the line value from the corresponding signal values. This process is shown in figure 2.
2. 5 T-wave morphology parameters
In order to characterize the T-wave morphology, a number of parameters were selected. The parameters were chosen to cover each of the three categories: Twave symmetry, T-wave flatness and duration. The parameters are listed and described in table 1.
Parameters S1-S4 and F1-F8 is based on the calculation of modified skewness and kurtosis measures defined as symmetry and flatness in the following. Inspired by the summary measures of probability distributions used in the field of statistics the T- waves were modelled as probability mass distributions (figure 3) and assigned a centre
(mean), width (standard deviation! an asvmmetrv measure and a convexitv measure. Asymmetry and convexity calculations were then carried out based on the modified skewness and kurtosis measures (3rd and 4th order moments) as follows:
The total area under the signal, mO, was calculated: N ΛΓ--\I n ∑V[n] n=0
The signal was normalized by the value of the area, mO: w[ \ = v[n] I m0
Normalization facilitated the calculation of the moment functions, since w[n] shares a fundamental property with the probability mass function: A total area of 1. The 1st order moment, ml, was calculated, ml is the mean of the signal:
N-\ m\ = ∑"*w| ] n=0
The 2 order moment, m2, was calculated. m2 is the standard deviation of the signal:
Figure imgf000021_0001
Figure 2 Isoelectric lines (dashed lines) in the signal are calculated from one P-Q interval to the following P-Q interval (Qstart - 20 ms). The line values are subtracted from the corresponding ECG signal values giving the distances v(n). The result of this procedure is shown as an area plot with basis on the zero-line.
Figure 3. a) Example probability mass distribution used when calculating standard skewness and kurtosis measures, b) Modified frequency distribution used in this study for calculating the modified skewness and kurtosis measures. Signal values v(n) are shown in figure 2. PARAMETER DESCRIPTION
Symmetry
51 Skewness evaluated from Tstart to Tend.
52 Skewness evaluated from Tstart to Tend with Ttop as mean. S3 Skewness evaluated in a symmetric interval, 10 % of the Tstart-Tend interval surrounding Ttop with Ttop as mean.
54 Skewness evaluated in a symmetric interval, 20 % of the Tstart-Tend interval surrounding Ttop wit Ttop as mean.
55 Ratio of the time interval from Tstart to Ttop and the time interval from Ttop to Tend.
56 Ratio of the average slope from Tstart to Ttop and from Ttop to Tend.
Flatness
Fl Kurtosis evaluated from Tstart to Tend. F2 Fl normalized by the absolute Rtop-Qnadir value. F3 Kurtosis evaluated from Tstart to Tend with Ttop as mean.
F4 F3 normalized by absolute Rtop-Qnadir value.
F5 Kurtosis evaluated in a symmetric interval, 10 % of the Tstart-Tend interval surrounding Ttop with Ttop as mean.
F6 F5 normalized by absolute Rtop-Qnadir value. F7 Kurtosis evaluated in a symmetric interval, 20 % of the Tstart-Tend interval surrounding Ttop with Ttop as mean.
F8 Kurtosis normalized by the value of Rtop with Ttop as mean.
F9 Ratio of the total area under the T-wave from Tstart to Ttop and the corresponding time interval. F 10 F9 normalized by absolute Rtop-Qnadir value.
Fl l Ratio of the total area under the T-wave from Ttop to Tend and the corresponding time interval. F13 Ratio of the total area under the T-wave from Tstart to Tend and the corresponding time interval.
F 14 F 13 normalized by absolute Rtop-Qnadir value.
F 15 Ratio of the height of Rtop and the width of the Tstart-Tend interval.
Duration
QTc The Q-T interval normalized by the square root of the R-R interval according to Bazett's formula.
D2 Time interval from Tstart to Tend. D3 Time interval from Tstart to Ttop. D4 Time interval from Ttop to Tend.
The table above shows a Complete list of the parameters used to characterize T-wave morphology. Parameters belong to one of three categories: symmetry, flatness and duration.
The 3rd order moment, m3, was calculated. m3 is the modified skewness of the signal:
Figure imgf000023_0001
Finally the 4* order moment, m.4, was calculated. m4 is the modified kurtosis of the signal:
Figure imgf000023_0002
2.6 Data analysis in Matlab
The T-wave morphology parameters for the acquired, pre-processed ECG recordings were evaluated using Matlab 6.0. Only valid data were analyzed - i.e. data from leads where the signal was not corrupted by high frequency noise and where the event detection algorithm was successful in detecting the relevant events with satisfactory precision. Parameter means and standard deviations were calculated for every T-wave in the signal on all leads. A great interlead variation in T-wave morphology may be an indicator of LQTS. Interlead variance was therefore examined by calculating the standard deviation of the lead means for each parameter.
Only the parameter means from lead N5 and interlead standard deviations were used as final parameter values. Hence, for every parameter in table 1 , two parameters were calculated - one with index "meanN5" and one with index "std" e.g. FlmeanN5 and Flstd.
2.7 Statistical analysis
In order to characterize and classify data from the three groups (KvLQTl, HERG and normal), the evaluated parameter values were processed using discriminant analysis. The analysis was carried out in SPSS version 11.5. The objective of the discriminant analysis was twofold: finding parameters that most efficiently discriminate between the groups and reducing the number of variables. Therefore a stepwise procedure was used with the Mahalanobis D2 as the most appropriate distance measure.
The entry/removal-criteria were adjusted in order to reduce the number of variables in the discriminant functions to achieve a 1:3 ratio between the number of variables and the population size (Ν=16). The criteria were empirically chosen to be penny = 0.045 and premoval = 0.09 providing the desired 5 variables in the discriminant functions.
Figure 4. Scatterplot showing classification of individuals by genotype. Separation of groups was carried out by 2 discriminant functions with 5 variables that characterize repolarisation by computation of symmetry, flatness and duration. 3. Results
The discriminant functions were based on data from all KvLQTl, HERG and normal subjects. The 5 parameters included in both discriminant functions are listed in table 2. The discriminative efficiency of both generated functions was statistically significant after inclusion of all 5 parameters (function 1: pO.OOOl, function 2: p<0.005).
Variables Entered
Figure imgf000025_0001
Table 2. Nariables used by the two discriminating functions. Stepwise introduction of more variables improved the ability of the functions to discriminate between KvLQTl, HERG and normal.
A scatterplot was generated from the discrimination functions and groupings of indi- vidual genotypes can be seen in figure 4. The dotted lines were read from the SPSS generated territorial map and manually added. The lines reflect borderlines where the differences between each pair of discrimination functions are zero. All 16 processed ECG's were correctly classified and showed at least one discriminatory characteristic as defined by the 5 parameters included in the discrimination functions. Cross valida- tion of both discriminant functions was done with the leave-one-out method and all 16 subjects were again correctly grouped. Reducing the number of variables resulted in misclassified cases due to lack of one or more discriminatory characteristics. In light - -c ii_ -_ r:„ J πni-aA -fin-flid- -ar lvcic of thp: sfiler.tfid Ωarameters in order to investigate the individual contributions of each variable to the separation of the three primary groups of subjects. Extreme values for all parameters were identified and the mean was computed.
The result is plotted in figure 5. As expected the extent of interlead flatness variation observed in HERG and normal individuals was lower than that found in KvLQTl subjects. This is evidenced by the Fl lstd parameter in figure 5a. When evaluating parameter values S4meanN5 and S5meanN5 (figure 5b, d) the extent of asymmetry in KvLQTl and normal was generally less than that of HERG individuals. Both S4meanV5 and S5meanN5 are symmetry parameters and asymmetry in HERG individuals was augmented in two ways: When bifid T-waves were present the interval from Tstart to Ttop was prolonged due to the definition of Ttop used in this study (the last highest point on the T-wave). Also, when the initial portion before Ttop was prolonged in HERG individuals better discrimination was possible. Both phenomena were observed in HERG subjects. Generally the Bazett corrected QTc observed in
HERG and KvLQTl was higher than that of normal individuals (figure 5e). However overlap existed between all three groups preventing separation of the groups by QTc. Since no single parameter included in the discrimination functions was able to separate KvLQTl, HERG and normal, we proceeded to investigate the classification effi- ciency provided by the three primary categories represented by the parameters in the functions. This was carried out by generating new discrimination functions using parameters from one category only while excluding the other two. Then, from the new discrimination functions three additional functions were generated, this time allowing the inclusion of parameters from combinations of two categories. Scatterplots illustrat- ing the results of this analysis are shown in figures 6a-f. The first two functions (figure 6a) included parameters that characterize the symmetrical properties of the Twave. 83.1% of the 16 subjects were correctly classified. Arrows in figure 6a indicate the 3 misclassified subjects. A second discriminant analysis was performed using flatness parameters. This resulted in 93.8% correctly classified subjects. Only one subject was not correctly classified as indicated by the arrow on figure 6b. The misclassified case was the same HERG subject incorrectly classified using symmetry parameters. The discriminatory efficiency of duration parameters was also evaluated. Discrimination nna1v<ji<3 p.ςnltp.d in 93.8% correctlv classified sub ects. One HERG subject was mis- waves similar to those found in KvLQTl. However the duration parameters failed to identify this morphological feature, thus reducing classification performance.
It can be noted that improved classification was obtained using flatness or duration parameters versus symmetry parameters and it seemed reasonable to investigate if further classification improvement could be achieved using a combination of several parameter categories.
Figure 5. a) Fllstd -Interlead standard deviation of the ratio between the total area under the T-wave from Ttop to Tend and the corresponding time interval, b)
S4meanN5 - Lead N5 mean modified skewness evaluated in a symmetrical interval surrounding Ttop and corresponding to 20% of the interval between Tstart-Tend. c) D4std - Interlead standard deviation of the time interval from Ttop to Tend, d) S5meanN5 - Lead N5 mean of the ratio between the time interval from Tstart to Ttop and the corresponding time interval from Ttop to Tend, e) Lead N5 mean QTc.
Figures 6d-f show the results of three separate discriminant analysis using combinations of parameters from two categories. It can be noted that classification of subjects was perfect in all cases, even when repolarisation duration was not considered (figure 6d).
4. Conclusion and discussion
The initial discriminant analysis performed in this study resulted in perfect classification of all KvLQTl, HERG and normal subjects. In table 2 it was noted that the discriminant functions included parameters from all three categories; T-wave symmetry, T-wave flatness and duration. This is in agreement with the initial hypothesis that a combination of repolarisation duration and T-wave morphology characteristics could improve discrimination between KvLQTl, HERG and normal.
To understand why some subjects were misclassified using a reduced set of parameter categories (figures 6a-c) the duration parameters and morphological characteristics of all 16 ECG's were examined. Using only symmetry parameters, 3 subjects were misclassified. However no obvious visual characteristics on the three misclassified ECG's could be identified that explained the incorrect classifications. The Bazett corrected QTc was 347ms for the normal subject, 425ms KvLQTl, 476ms HERG. Although an obviously prolonged QTc was present in the misclassified HERG subject it was not identified using symmetry parameters alone.
Discriminant analysis using parameters from the flatness category resulted in only 1 misclassification. Again no visual characteristics were identified to account for the misclassification. Although it was anticipated that the
Figure 6. a) The result of discriminant analysis using symmetry parameters resulted in three misclassified cases (arrows). Visual inspection of the ECG's revealed no apparent abnormalities to indicate the reason for incorrect misclassification. b) The result of discriminant analysis using flatness parameters. One incorrectly classified HERG subject was identified (arrow) even though no obvious visual abnormality indicated a different genotype, c) Result of discriminant analysis using duration parameters. This result illustrates the failure of duration parameters to discriminate between KvLQTl, HERG and normal (arrow), d-e) Combinations of parameters from two categories illustrate the improvement in classification efficiency when compared to figures 6a-c evaluation of T-wave flatness would be able to discriminate HERG from KvLQTl subjects this was not accomplished by using flatness as a single descriptor of repolarisation. Performing discriminant analysis based on the QTc parameter as the only variable resulted in 1 misclassification. This was not unexpected since it is well known that a substantial overlap in QTc values can exist between normal and affected individuals. The lack of unambiguous discrimination between all groups by use of the
QTc parameter alone emphasizes the hypothesis that additional parameters are needed to classify LQTS individuals. By combining parameters from two categories it was found that the discriminatory strength was increased.
(figures 6d-f) This was evidenced by the fact that no subjects were misclassified using two categories. A particularly interesting finding, was the perfect separation of all subjects that was obtained using symmetry and flatness parameters with no duration pa- -„,--, aia~c
Figure imgf000028_0001
Tnϊo r»cmit imnlipo f p rli<!primiτιatnrv strenprh inherent in ϋarame- ters from those two categories. In addition it was found that symmetry or flatness parameters combined with duration parameters yielded perfect discrimination between all groups. Results from the discriminant analysis using one and two categories indicate that a combination of more parameter categories strengthen the overall discrimi- natory power of the classification functions. Combining these findings with the results from the three category discriminant analysis initially performed, it is reasonable to speculate that a substantially improved discrimination between KvLQTl, HERG and normal is possible using all three categories of parameters.
In light of the results obtained in this study we propose a new technique for discriminating between KvLQTl, HERG and normal subjects. Through multivariate discriminant analysis it was found that a combination of two duration parameters and three T- wave symmetry-and flatness parameters was sufficient to classify each of the 16 study subjects into one of the three distinct groups. Although no single parameter had the necessary discriminatory strength to classify the subjects, the combination of multiple parameters in two discrimination functions was statistically significant (function 1: p<0.0001, function 2: p<0.005). The encouraging results of multivariate repolarisation analysis found in this study support the use of symmetry-, flatness- and duration parameters to classify LQTS patients.
The use of the proposed multiple parameter categories to classify KvLQTl and HERG genotypes may prove to be a powerful clinical tool in the making.

Claims

1. A system for analysing ECG curvature wherein at least one among a number of different parameters is isolated and stored, which system has input means connected to an ECG source, where the different parameters of a received ECG curvature are indicated and/or isolated for indicating symptoms, where a first number of selected parameters from at least three main groups, which groups comprise parameters of symmetry, flatness, duration and/or complexity, are combined in at least a first mathematical analysis, where the result of the analysis is represented as a point in at least one coordinate system, comprising at least one axis, where the system compares the actual coordinates in the coordinate system with a number of reference parameters stored in the system, for indicating symptoms or diseases having influence on the ECG curvature, where the system analyses the QT curvature of the ECG for indicating hereditary or acquired Long QT Syndrome.
2. A system for analysing ECG curvature according to claim 1, characterised in that the system is analysing ECG curvature for Long QT Syndrome acquired by drug influence.
3. System according to one of the claims 1-2, characterisedin that the analysing process is repeated in the system for further selected parameters in order to achieve more reliable results.
4. System according to one of the claims 1-3, characterised in that the group of symmetry comprises at least the following parameters:
51 Symmetry evaluated from Tstart to Tend.
52 Symmetry with Tpeak as mean evaluated from Tstart to Tend.
S3 Symmetry with Tpeak as mean evaluated in a symmetric interval of 10% of the Tstart-Tend-interval surrounding Tpeak.
S4 Symmetry with Tpeak as mean evaluated in a symmetric interval of 20% of the Tstart-Tend-interval surrounding Tpeak. 55 Ratio of the time interval "Tstart to Tpeak" and the time interval "Tpeak to Tend.
56 Ratio of the average slope from Tstart to Tpeak and from Tpeak to Tend.
57 Variation evaluated from Tstart to Tend, calculated by the formula.
58 Variation with Tpeak as mean evaluated from Tstart to Tend. S9 Variation with Tpeak as mean evaluated in a symmetric interval of 10% of the Tstart-Tend-interval surrounding Tpeak.
510 Variation with Tpeak as mean evaluated in a symmetric interval of 20% of the Tstart-Tend-interval surrounding Tpeak.
511 The Hill parameter, K^, evaluated by least square fitting of the repolarisation integral, RI(t), from the Jpoint to the following Ponset.
S12 The Hill parameter, K,,,, evaluated by least square fitting of the repolarisation integral, RI(t), from Tstart to Tend.
5. System according to one of the claim l-3, c h a r a c t e r i s e d in that the group of flatness comprises at least the following parameters:
Fl Flatness evaluated from Tstart to.
F2 Flatness parameter, F 1 , normalized by the size of the R wave.
F3 Flatness with Tpeak as mean evaluated from Tstart to Tend.
F4 Flatness parameter, F3, normalized by the size of the R wave.
F5 Flatness with Tpeak as mean evaluated in a symmetric interval of 10% of the Tstart-Tend-interval surrounding Tpeak.
F6 Flatness parameter, F5, normalized by the size of the R wave.
F7 Flatness with Tpeak as mean evaluated in a symmetric interval of 20% of the Tstart-Tend-interval surrounding Tpeak.
F8 Flatness parameter, F7, normalized by the size of the R wave.
F9 Ratio of the total area under the T-wave from Tstart to Tpeak and the corresponding time interval. F 10 Flatness parameter, F9, normalized by the size of the R wave. Fl l Ratio of the total area under the T-wave from Tpeak to Tend and the corresponding time interval.
F 12 Flatness parameter, Fll, normalized by the size of the R wave.
F13 Ratio of the total area under the T-wave from Tstart to Tend and the corresponding time interval.
F 14 Flatness parameter, F 13 , normalized by the size of the R wave.
F 15 Ratio of the T wave height and the T wave width.
F 16 The T wave height. F 17 Average slope from Tstart to Tpeak.
F 18 Average slope from Tpeak to Tend.
F19 The Hill parameter, n, evaluated by least square fitting of the repolarisation integral, RI(t), from the Jpoint to the following Ponset. F20 The Hill parameter, n, evaluated by least square fitting of the repolarisation integral, RI(t), from Tstart to Tend F21 The Hill parameter, Vmax, evaluated by least square fitting of the repolarisation integral, RI(t), from the Jpoint to the following Ponset.
F22 The Hill parameter, Nnax, evaluated by least square fitting of the repolarisation integral, RI(t), from Tstart to Tend.
6. System according to one of the claims l-3, c h a r a c t e r i s e d in that the group of duration comprises at least the following parameters:
QTc The Q-T interval normalized by the square root of the R-R interval according to Bazett' s foπnula.
D2 The time interval from Tstart to Tend.
D3 The time interval from Tstart to Tpeak.
D4 The time interval from Tpeak to Tend
7. System according to one of the claims l-3, c h a r a c t e r i s e d in that the group Cl : Number of local maxima between Tstart and Tend; the minimum number is one. C2: Number of phases between Tstart and Tend, where a phase is defined as a singly connected part of the wave that is entirely above or entirely below the iso-electric line; the minimum number is one.
8. System according to one of the claims 1-7, characterisedin that the system is selecting and combining parameters from different groups.
9. System according to one of the claims 1-8, characterisedin that the system is trained during use, where the parameters' values are calculated for individual subjects, where the mathematical analysis of the parameters chooses at least one optimal small parameter set out of the complete number of parameters from all categories.
10. System according to one of the claims 1-10, characterisedin that the fi- nal classification function is at least based on data from at least one LQT or drug influenced group and Normal subjects stored as a training set, with the consequences that the classification method is improved by adding new subjects to the training set, which new subject can be tailored to demographic or gender differences.
11. Method for analysing drug influence on ECG curvature, which curvature contains a number of parameters, characterised in that the method for analysing the ECG curvature incorporates the steps of:
a) receiving ECG curvature from a source, b) indicating a number of different parameters contained in the received ECG curvature, c) storing the parameters in storage means, d) selecting disease specific parameters in the storage means e) selecting parameters from at least three groups, which groups comprises parame- ters of syimnetry, flatness, duration and/or complexity. f) combining selected parameters in mathematical analysing means g) representing the result of the mathematical analysis as a point in at least one p.nnrrHnate svstp.m which mnrHinatp. <jv<3TP.m rr>mrvri<ιp<j at Ipa t nne avis h) comparing the actual placement in the coordinate system with a number of reference parameters stored in a memory, i) analysing the QT curvature of the ECG for indicating drug induced changes.
12. Method according to claim 11, c h a r a c t e r i s e d in that the method is repeating the analysing process for further selected parameters for achieving more reliable results.
13. Use of a system for analysing ECG curvature for test of drugs, which system has input means connected to an ECG source, wherein at least one among a number of different parameters is isolated and stored in the system, where the different parameters of a received ECG curvature are indicated and/or isolated for indicating possible symptoms, where a number of selected parameters, are combined in at least a first mathematical analysis, where the result of the analysis is represented as a point in at least one coordinate system, comprising at least one axis, where the system compares the actual placement in the coordinate system with a number of reference parameters stored in the system, for indicating symptoms having influence on the ECG curvature, where the parameters of the ECG curvature are calculated before and after a drug test for a number of subjects, where the difference for selected parameters between before and after testing are calculated for each subject, where the system analyses the QT curvature of the ECG for indicating acquired Long QT syndrome, where a statistical analysis of selected parameters for a number of subjects gives statistical significance for at least one of the following decisions: "accept of the drug" "rejection of the drug"
"further testing of the drug".
PCT/DK2004/000722 2003-12-19 2004-10-20 A system and a method for analysing ecg curvature for long qt syndrome and drug influence WO2005058156A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/596,617 US7991458B2 (en) 2003-12-19 2004-10-20 System and a method for analysing ECG curvature for long QT syndrome and drug influence
JP2006544212A JP2007514488A (en) 2003-12-19 2004-10-20 System and method for analyzing electrocardiogram curvature and drug effects in long QT syndrome
CA002550224A CA2550224A1 (en) 2003-12-19 2004-10-20 A system and a method for analysing ecg curvature for long qt syndrome and drug influence
EP04762941A EP1696792A1 (en) 2003-12-19 2004-10-20 A system and a method for analysing ecg curvature for long qt syndrome and drug influence

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53066503P 2003-12-19 2003-12-19
EP03029363A EP1543770A1 (en) 2003-12-19 2003-12-19 A system and a method for analysing an ECG signal
EP03029363.3 2003-12-19
US60/530,665 2003-12-19

Publications (1)

Publication Number Publication Date
WO2005058156A1 true WO2005058156A1 (en) 2005-06-30

Family

ID=34486260

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2004/000722 WO2005058156A1 (en) 2003-12-19 2004-10-20 A system and a method for analysing ecg curvature for long qt syndrome and drug influence

Country Status (6)

Country Link
US (1) US7991458B2 (en)
EP (2) EP1543770A1 (en)
JP (1) JP2007514488A (en)
CN (1) CN1953705A (en)
CA (1) CA2550224A1 (en)
WO (1) WO2005058156A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007106781A2 (en) * 2006-03-10 2007-09-20 University Of Rochester Ecg-based differentiation of lqt1 and lqt2 mutation
WO2008064679A1 (en) * 2006-11-30 2008-06-05 Aalborg Universitet System and method for analyzing complex curvature of ecg curves
US20100004549A1 (en) * 2006-10-03 2010-01-07 General Electric Company System and method of serial comparison for detection of long qt syndrome (lqts)
US7840259B2 (en) 2006-11-30 2010-11-23 General Electric Company Method and system for electrocardiogram evaluation

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7520860B2 (en) 2005-04-13 2009-04-21 Marie G. Johnson Detection of coronary artery disease using an electronic stethoscope
JP4972639B2 (en) 2005-05-06 2012-07-11 バソノバ・インコーポレイテッド Method and apparatus for guiding and positioning an intravascular device
US20090118612A1 (en) 2005-05-06 2009-05-07 Sorin Grunwald Apparatus and Method for Vascular Access
US7529580B2 (en) 2005-08-11 2009-05-05 Pacesetter, Inc. Detection of renal failure by cardiac implantable medical device
US7400920B1 (en) 2005-08-11 2008-07-15 Pacesetter, Inc. Detection of renal failure by cardiac implantable medical device
US7676264B1 (en) * 2007-04-13 2010-03-09 Pacesetter, Inc. Systems and methods for use by an implantable medical device for evaluating ventricular dyssynchrony based on T-wave morphology
EP2170162B1 (en) 2007-06-26 2017-08-23 Vasonova, Inc. Apparatus for endovascular device guiding and positioning using physiological parameters
US8116859B2 (en) 2007-10-24 2012-02-14 Ela Medical S.A.S. Electrocardiologic device for the assisted diagnosis of brugada syndrome or early repolarization syndrome
JP4986817B2 (en) * 2007-11-13 2012-07-25 株式会社ソニーDadc Evaluation device, evaluation method, program
EP2637568B1 (en) 2010-11-08 2017-04-12 Vasonova, Inc. Endovascular navigation system
JP6185048B2 (en) 2012-05-07 2017-08-23 バソノバ・インコーポレイテッドVasonova, Inc. System and method for detection of superior vena cava area and vena cava atrial junction
US9307908B2 (en) 2012-10-30 2016-04-12 Vital Connect, Inc. Measuring psychological stress from cardiovascular and activity signals
US9980678B2 (en) 2012-10-30 2018-05-29 Vital Connect, Inc. Psychological acute stress measurement using a wireless sensor
US10213146B2 (en) 2012-10-30 2019-02-26 Vital Connect, Inc. Measuring psychological stress from cardiovascular and activity signals
CN104726492A (en) * 2015-01-20 2015-06-24 深圳市三启生物技术有限公司 Method for constructing LQT disease model and application of LQT disease model in drug screening
WO2017180617A1 (en) * 2016-04-11 2017-10-19 Vital Connect, Inc. Psychological acute stress measurement using a wireless sensor
CA3226236A1 (en) 2016-05-19 2017-12-14 Tabula Rasa Healthcare, Inc. Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications
US11337637B2 (en) 2016-08-31 2022-05-24 Mayo Foundation For Medical Education And Research Electrocardiogram analytical tool
US11191459B2 (en) 2016-09-12 2021-12-07 Mayo Foundation For Medical Education And Research ECG-based analyte assessments with adjustments for variances in patient posture
CN108403105B (en) * 2017-02-09 2020-11-03 深圳市理邦精密仪器股份有限公司 Display method and display device for electrocardio scatter points

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019452A1 (en) * 1990-06-20 1991-12-26 Cedars-Sinai Medical Center Methods for detecting and evaluating heart disorders
US5419338A (en) * 1994-02-22 1995-05-30 City Of Hope Autonomic nervous system testing by bi-variate spectral analysis of heart period and QT interval variability
US5749367A (en) 1995-09-05 1998-05-12 Cardionetics Limited Heart monitoring apparatus and method
US5803084A (en) * 1996-12-05 1998-09-08 Olson; Charles Three dimensional vector cardiographic display and method for displaying same
US6324423B1 (en) * 1998-04-17 2001-11-27 Timothy Callahan Quantitative method and apparatus for measuring QT intervals from ambulatory electrocardiographic recordings
US6389308B1 (en) * 2000-05-30 2002-05-14 Vladimir Shusterman System and device for multi-scale analysis and representation of electrocardiographic data
GB2387442A (en) * 2002-04-09 2003-10-15 Anthony Charles Hunt Electrocardiogram QT interval measurement

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6684100B1 (en) * 2000-10-31 2004-01-27 Cardiac Pacemakers, Inc. Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019452A1 (en) * 1990-06-20 1991-12-26 Cedars-Sinai Medical Center Methods for detecting and evaluating heart disorders
US5419338A (en) * 1994-02-22 1995-05-30 City Of Hope Autonomic nervous system testing by bi-variate spectral analysis of heart period and QT interval variability
US5749367A (en) 1995-09-05 1998-05-12 Cardionetics Limited Heart monitoring apparatus and method
US5803084A (en) * 1996-12-05 1998-09-08 Olson; Charles Three dimensional vector cardiographic display and method for displaying same
US6324423B1 (en) * 1998-04-17 2001-11-27 Timothy Callahan Quantitative method and apparatus for measuring QT intervals from ambulatory electrocardiographic recordings
US6389308B1 (en) * 2000-05-30 2002-05-14 Vladimir Shusterman System and device for multi-scale analysis and representation of electrocardiographic data
US20020143263A1 (en) 2000-05-30 2002-10-03 Vladimir Shusterman System and device for multi-scale analysis and representation of physiological data
GB2387442A (en) * 2002-04-09 2003-10-15 Anthony Charles Hunt Electrocardiogram QT interval measurement

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KANTERS ET AL.: "T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome", HEART RHYTHM, vol. 3, 2004, pages 285 - 292
KANTERS ET AL.: "T wave morphology analysis distinguishes between KvLQTl and HERG mutations in long QT syndrome", HEART RHYTHM, vol. 3, 2004, pages 285 - 292

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007106781A2 (en) * 2006-03-10 2007-09-20 University Of Rochester Ecg-based differentiation of lqt1 and lqt2 mutation
WO2007106781A3 (en) * 2006-03-10 2008-04-03 Univ Rochester Ecg-based differentiation of lqt1 and lqt2 mutation
US20100004549A1 (en) * 2006-10-03 2010-01-07 General Electric Company System and method of serial comparison for detection of long qt syndrome (lqts)
WO2008064679A1 (en) * 2006-11-30 2008-06-05 Aalborg Universitet System and method for analyzing complex curvature of ecg curves
DE112007002930T5 (en) 2006-11-30 2010-04-29 Aalborg Universitet System and method for analyzing the complex curvature of ECG waveforms
US7840259B2 (en) 2006-11-30 2010-11-23 General Electric Company Method and system for electrocardiogram evaluation
US8260406B2 (en) 2006-11-30 2012-09-04 Aalborg Universitet System and method for analyzing complex curvature of ECG curves

Also Published As

Publication number Publication date
JP2007514488A (en) 2007-06-07
US7991458B2 (en) 2011-08-02
EP1543770A1 (en) 2005-06-22
EP1696792A1 (en) 2006-09-06
US20070208264A1 (en) 2007-09-06
CN1953705A (en) 2007-04-25
CA2550224A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
US7991458B2 (en) System and a method for analysing ECG curvature for long QT syndrome and drug influence
Satija et al. A review of signal processing techniques for electrocardiogram signal quality assessment
Chen et al. An automatic R and T peak detection method based on the combination of hierarchical clustering and discrete wavelet transform
Oweis et al. QRS detection and heart rate variability analysis: A survey
Park et al. Arrhythmia detection from heartbeat using k-nearest neighbor classifier
US7477936B2 (en) System and a method for analyzing ECG curvature
EP2688468B1 (en) Apparatus and method for measuring physiological signal quality
EP2895063B1 (en) A system and method for detecting the presence of a p-wave in an ecg waveform
Chiu et al. Using correlation coefficient in ECG waveform for arrhythmia detection
Tan et al. Detection of the QRS complex, P wave and T wave in electrocardiogram
US10342449B2 (en) Electrocardiogram device and methods
US6607480B1 (en) Evaluation system for obtaining diagnostic information from the signals and data of medical sensor systems
Henzel et al. Atrial fibrillation episodes detection based on classification of heart rate derived features
CN111329455A (en) Non-contact cardiovascular health assessment method
Işler et al. Heart rate normalization in the analysis of heart rate variability in congestive heart failure
Leutheuser et al. Instantaneous P-and T-wave detection: Assessment of three ECG fiducial points detection algorithms
Papadogiorgaki et al. Heart rate classification using ECG signal processing and machine learning methods
Hugeng et al. Development of the ‘Healthcor’system as a cardiac disorders symptoms detector using an expert system based on arduino uno
Mahamat et al. Wolff-Parkinson-White (WPW) syndrome: the detection of delta wave in an electrocardiogram (ECG)
Simjanoska et al. ECG-derived Blood Pressure Classification using Complexity Analysis-based Machine Learning.
Lombardi et al. Detecting sepsis from photoplethysmography: strategies for dataset preparation
Kumar et al. Robust multiresolution wavelet analysis and window search based approach for electrocardiogram features delineation
Hammed et al. Patient adaptable ventricular arrhythmia classifier using template matching
Dharma et al. Hypertension Identification Using Naive Bayes Classification Method and Pan Tompkins Feature Extraction
Gharaviri et al. Ischemia detection via ECG using ANFIS

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480041880.1

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2550224

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006544212

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 2004762941

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2626/CHENP/2006

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: 2004762941

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007208264

Country of ref document: US

Ref document number: 10596617

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10596617

Country of ref document: US